Delivery Order SPE2DB22D3102-SPE2DB24FL2NC

Award Date 8/14/24
Potential Completion Date 8/15/24
Potential Value $4.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $5,348.56 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Rifampin 150 mg capsules, with a performance period through May 20, 2025. Amerisourcebergen Drug Corp is a for-profit organization and a critical supplier of medical and pharmaceutical products to federal agencies, including the military healthcare system. The company holds a significant...
This is a $18,739.89 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the supply of Rifampin 300 mg capsules, with a period of performance through July 26, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, to provide a wide range of essential...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,160,692 units of Rifampin 300 mg capsules. The contract has a ceiling value of $5,109.58 and a period of performance through May 7, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,133,489 units of rifampin 300 mg capsules. The contract, valued at $1,098.31, has an ultimate completion date of July 15, 2024 and was awarded on July 12, 2024. The contract is a delivery order with a firm fixed-price pricing type, issued by the Defense agency Medical Supply Chain. Amerisourcebergen, a major pharmaceutical distribution company, does not have a set-aside designation...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,458.20 firm fixed-price contract is for the delivery of Rifampin 300 mg capsules, a critical medication used to treat various infectious diseases. The contract has a completion date of February 26, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RIFAMPIN 150 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $6,922.86 and a completion date of May 30, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical to provide 4,565,453,612 units of the drug Rifampin 300 mg capsules. The contract is a Delivery Order with a Firm Fixed Price of $13,361.76 and has an ultimate completion date of August 15, 2024. The contract is not designated as a Set-Aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $3,184.80 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RIFAMPIN 150 MG CAPSULE 30S, a prescription medication, with a period of performance through May 28, 2025. The contract is not set aside and was awarded as a standalone delivery order. However, Amerisourcebergen Drug Corp also holds a larger $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,243,500 units of Rifampin 300 mg capsules. The award has a ceiling value of $61,426.00 and a period of performance through July 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The contract, valued at $7,142.48, is for the delivery of 4,565,178,615 units of Rifampin 300 mg capsules. This is a Firm Fixed Price Delivery Order contract with a completion date of July 18, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery...
  • SPE2DB22D3102
    Indefinite Delivery Contract
  • SPE2DB22D3102-SPE2DB24FL2NC
    Delivery Order

This is a $4,868.88 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of 4,565,455,089 units of Rifampin 150 mg capsules. The contract has an ultimate completion date of August 15, 2024 and was awarded on August 14, 2024. AmerisourceBergen is a large pharmaceutical distributor that has been awarded multiple indefinite delivery contracts (IDCs) by DLA and other federal agencies to provide a wide range of pharmaceutical and medical supplies in support of military treatment programs and federal healthcare needs. This particular delivery order is likely part of one of AmerisourceBergen's existing IDCs with DLA, which can be valued up to $999,999,999 through December 2025 for medical commodities. No set-aside was used for this award.

Generated 11/13/24, 9:25 AM